Biomea Fusion, Inc. Common Stock (BMEA) is a publicly traded Healthcare sector company. As of May 21, 2026, BMEA trades at $1.33 with a market cap of $90.37M and a P/E ratio of -1.09. BMEA moved +9.84% today. Year to date, BMEA is +3.91%; over the trailing twelve months it is -15.29%. Its 52-week range spans $0.87 to $13.07. Analyst consensus is buy with an average price target of $7.20. Rallies surfaces BMEA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Biomea Fusion, Inc. Common Stock (BMEA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BMEA moved +9.84% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.33 |
| Market Cap | $90.37M |
| P/E Ratio | -1.09 |
| EPS | $-1.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.07 |
| 52-Week Low | $0.87 |
| Volume | 250 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.86M |
| Net Income | $-61.80M |
| Gross Margin | 0.00% |
6 analysts cover BMEA: 0 strong buy, 5 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.20.